A citation-based method for searching scientific literature

Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders.
Masaya Tachibana, Kuriko Kagitani-Shimono, Ikuko Mohri, Tomoka Yamamoto, Wakako Sanefuji, Ayumi Nakamura, Masako Oishi, Tadashi Kimura, Tatsushi Onaka, Keiichi Ozono, Masako Taniike. J Child Adolesc Psychopharmacol 2013
Times Cited: 115



Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders.
Eric Hollander, Sherie Novotny, Margaret Hanratty, Rona Yaffe, Concetta M DeCaria, Bonnie R Aronowitz, Serge Mosovich. Neuropsychopharmacology 2003
Times Cited: 424




List of shared articles



Times cited

The Current Status of Drug Discovery for the Oxytocin Receptor.
Philippe E Nashar, Aidan A Whitfield, Jiri Mikusek, Tristan A Reekie. Methods Mol Biol 2022
1

Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis.
Yi Huang, Xin Huang, Richard P Ebstein, Rongjun Yu. Neurosci Biobehav Rev 2021
20

Acupuncture and oxytocinergic system: The promising treatment for autism.
Tangfeng Su, Lei Pei. Transl Neurosci 2021
3

The promiscuity of the oxytocin-vasopressin systems and their involvement in autism spectrum disorder.
Amelie M Borie, Constantina Theofanopoulou, Elissar Andari. Handb Clin Neurol 2021
4

Autistic-like behaviours and associated brain structural plasticity are modulated by oxytocin in maternally separated rats.
Monireh Mansouri, Hamidreza Pouretemad, Mehrdad Roghani, Gregers Wegener, Maryam Ardalan. Behav Brain Res 2020
9

Social Interaction Improved by Oxytocin in the Subclass of Autism with Comorbid Intellectual Disabilities.
Haruhiro Higashida, Toshio Munesue, Hirotaka Kosaka, Hidenori Yamasue, Shigeru Yokoyama, Mitsuru Kikuchi. Diseases 2019
17

Overview of Human Oxytocin Research.
Keith M Kendrick, Adam J Guastella, Benjamin Becker. Curr Top Behav Neurosci 2018
36

Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents.
Richard E Frye. CNS Drugs 2018
37

LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
Marie-Céline Frantz, Lucie P Pellissier, Elsa Pflimlin, Stéphanie Loison, Jorge Gandía, Claire Marsol, Thierry Durroux, Bernard Mouillac, Jérôme A J Becker, Julie Le Merrer,[...]. J Med Chem 2018
14

Opportunities and challenges for intranasal oxytocin treatment studies in nonhuman primates.
Melissa D Bauman, Takeshi Murai, Casey E Hogrefe, Michael L Platt. Am J Primatol 2018
6

Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism.
Yu-Chuan Dai, Hong-Feng Zhang, Michael Schön, Tobias M Böckers, Song-Ping Han, Ji-Sheng Han, Rong Zhang. Front Cell Neurosci 2018
29

From bedside to bench and back: Translating ASD models.
Hayley P Drozd, Sotirios F Karathanasis, Andrei I Molosh, Jodi L Lukkes, D Wade Clapp, Anantha Shekhar. Prog Brain Res 2018
0

Oxytocin and Autism Spectrum Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yoon Phaik Ooi, Shih-Jen Weng, Joe Kossowsky, Heike Gerger, Min Sung. Pharmacopsychiatry 2017
62

Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.
Gail A Alvares, Daniel S Quintana, Andrew J O Whitehouse. Autism Res 2017
40

What Have Proteomic Studies Taught Us About Novel Drug Targets in Autism?
Paul C Guest, Daniel Martins-de-Souza. Adv Exp Med Biol 2017
0

The role of cholesterol metabolism and various steroid abnormalities in autism spectrum disorders: A hypothesis paper.
Christopher Gillberg, Elisabeth Fernell, Eva Kočovská, Helen Minnis, Thomas Bourgeron, Lucy Thompson, Clare S Allely. Autism Res 2017
30

The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder.
Rong Zhang, Xin-Jie Xu, Hong-Feng Zhang, Song-Ping Han, Ji-Sheng Han. Adv Anat Embryol Cell Biol 2017
11

Oxytocin Treatment, Circuitry, and Autism: A Critical Review of the Literature Placing Oxytocin Into the Autism Context.
Adam J Guastella, Ian B Hickie. Biol Psychiatry 2016
123

Promising evidence and remaining issues regarding the clinical application of oxytocin in autism spectrum disorders.
Hidenori Yamasue. Psychiatry Clin Neurosci 2016
39

From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders.
Adele Romano, Bianca Tempesta, Maria Vittoria Micioni Di Bonaventura, Silvana Gaetani. Front Neurosci 2016
62

Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study.
Toshio Munesue, Hiroyuki Nakamura, Mitsuru Kikuchi, Yui Miura, Noriyuki Takeuchi, Tokie Anme, Eiji Nanba, Kaori Adachi, Kiyotaka Tsubouchi, Yoshimichi Sai,[...]. Front Psychiatry 2016
51

Conditioned social preference, but not place preference, produced by intranasal oxytocin in female mice.
Yutaka Kosaki, Shigeru Watanabe. Behav Neurosci 2016
17

The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.
Yuko Okamoto, Makoto Ishitobi, Yuji Wada, Hirotaka Kosaka. CNS Neurol Disord Drug Targets 2016
24

Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.
Tatiana M Kazdoba, Prescott T Leach, Mu Yang, Jill L Silverman, Marjorie Solomon, Jacqueline N Crawley. Curr Top Behav Neurosci 2016
78

The neurocircuitry involved in oxytocin modulation of methamphetamine addiction.
Sarah J Baracz, Jennifer L Cornish. Front Neuroendocrinol 2016
31

Novel mechanisms and treatment approaches in autism spectrum disorder.
Jessica Brian, Krissy Doyle-Thomas, Danielle Baribeau, Evdokia Anagnostou. Discov Med 2016
3

Clinical trial of modulatory effects of oxytocin treatment on higher-order social cognition in autism spectrum disorder: a randomized, placebo-controlled, double-blind and crossover trial.
Katrin Preckel, Philipp Kanske, Tania Singer, Frieder M Paulus, Sören Krach. BMC Psychiatry 2016
14

Oxytocin's neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial.
Y Aoki, T Watanabe, O Abe, H Kuwabara, N Yahata, Y Takano, N Iwashiro, T Natsubori, H Takao, Y Kawakubo,[...]. Mol Psychiatry 2015
71

[Oxytocin in the treatment of the social deficits associated to autism spectrum disorders].
Carla Cachafeiro-Espino, Anna M Vale-Martínez. Rev Neurol 2015
0

Is Oxytocin Application for Autism Spectrum Disorder Evidence-Based?
Seung Yup Lee, Ah Rah Lee, Ram Hwangbo, Juhee Han, Minha Hong, Geon Ho Bahn. Exp Neurobiol 2015
19

Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial.
Mark R Dadds, Elayne MacDonald, Avril Cauchi, Katrina Williams, Florence Levy, John Brennan. J Autism Dev Disord 2014
163

An update on medication management of behavioral disorders in autism.
Danielle A Baribeau, Evdokia Anagnostou. Curr Psychiatry Rep 2014
28

Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth.
Evdokia Anagnostou, Latha Soorya, Jessica Brian, Annie Dupuis, Deepali Mankad, Sharon Smile, Suma Jacob. Brain Res 2014
100

Social Communication is an Emerging Target for Pharmacotherapy in Autism Spectrum Disorder - A Review of the Literature on Potential Agents.
Danielle A Baribeau, Evdokia Anagnostou. J Can Acad Child Adolesc Psychiatry 2014
12

What's in the pipeline? Drugs in development for autism spectrum disorder.
Min Sung, Chee Hon Chin, Choon Guan Lim, Hwee Sen Alvin Liew, Chau Sian Lim, Espérance Kashala, Shih-Jen Weng. Neuropsychiatr Dis Treat 2014
6

Oxytocin and autism: a systematic review of randomized controlled trials.
Antonio Preti, Mariangela Melis, Sara Siddi, Marcello Vellante, Giuseppe Doneddu, Roberta Fadda. J Child Adolesc Psychopharmacol 2014
69


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy